Cite
HARVARD Citation
Zak, M. et al. (2019). Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. Bioorganic & medicinal chemistry letters. 29 (12), pp. 1522-1531. [Online].